• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Genetic characterization of an adapted pandemic 2009 H1N1 influenza virus that reveals improved replication rates in human lung epithelial cells

tetano

Editor, Senior Moderator
Virology. 2016 Feb 22;492:118-129. doi: 10.1016/j.virol.2016.02.002. [Epub ahead of print]
[h=1]Genetic characterization of an adapted pandemic 2009 H1N1 influenza virus that reveals improved replication rates in human lung epithelial cells.[/h] W?rmann X[SUP]1[/SUP], Lesch M[SUP]2[/SUP], Welke RW[SUP]3[/SUP], Okonechnikov K[SUP]1[/SUP], Abdurishid M[SUP]1[/SUP], Sieben C[SUP]3[/SUP], Geissner A[SUP]4[/SUP], Brinkmann V[SUP]1[/SUP], Kastner M[SUP]5[/SUP], Karner A[SUP]6[/SUP], Zhu R[SUP]5[/SUP], Hinterdorfer P[SUP]5[/SUP], Anish C[SUP]7[/SUP], Seeberger PH[SUP]4[/SUP], Herrmann A[SUP]3[/SUP], Meyer TF[SUP]8[/SUP], Karlas A[SUP]9[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The 2009 influenza pandemic originated from a swine-origin H1N1 virus, which, although less pathogenic than anticipated, may acquire additional virulence-associated mutations in the future. To estimate the potential risk, we sequentially passaged the isolate A/Hamburg/04/2009 in A549 human lung epithelial cells. After passage 6, we observed a 100-fold increased replication rate. High-throughput sequencing of viral gene segments identified five dominant mutations, whose contribution to the enhanced growth was analyzed by reverse genetics. The increased replication rate was pinpointed to two mutations within the hemagglutinin (HA) gene segment (HA[SUB]1[/SUB] D130E, HA[SUB]2[/SUB] I91L), near the receptor binding site and the stem domain. The adapted virus also replicated more efficiently in mice in vivo. Enhanced replication rate correlated with increased fusion pH of the HA protein and a decrease in receptor affinity. Our data might be relevant for surveillance of pre-pandemic strains and development of high titer cell culture strains for vaccine production.
Copyright ? 2016 The Authors. Published by Elsevier Inc. All rights reserved.


[h=4]KEYWORDS:[/h] A/Hamburg/04/2009; Hemagglutinin; High-throughput sequencing; Reverse genetics; Viral adaptation

PMID: 26914510 [PubMed - as supplied by publisher]
 
Back
Top Bottom